FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacquie Astemborski

Research Profile

Activities & Behaviors

Intravenous Substance Abuse

Disorders

Concepts & Ideas

Living Beings

Phenomena

HIV Seropositivity

Procedures

Co-author Network

Publications

TOP 3
Gregory D Kirk; Shruti H Mehta; Jonathan Washington; Jacquie Astemborski; Ashwin Balagopal; Noya Galai; Yvonne Higgins; David L Thomas
HIV, Age, and the Severity of Hepatitis C Virus-Related Liver Disease: A Cohort Study.
Ludmila Prokunina-Olsson; Barbara Rehermann; Faruk Sheikh; Wei Tang; McAnthony Tarway; David L Thomas; Heiyoung Park; Ruth M Pfeiffer; Patricia Porter-Gill; Jacquie Astemborski; Herbert L Bonkovsky; Nathan Brand; Sabrina Chen; Harold Dickensheets; Raymond P Donnelly; Brian R Edlin; Dianna Hergott; Charles D Howell; Indu kohaar; Luyang Liu; Timothy R Morgan; Brian Muchmore; Adam Mumy; Thomas R O'Brien
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
Oliver Laeyendecker; Joseph B Margolick; Shruti Hemendra Mehta; Caroline E Mullis; Thomas C Quinn; George R Seage; Lisa P Jacobson; Gregory D Kirk; Jacob Konikoff; Jacquie Astemborski; Ron Brookmeyer; Joelle Brown; Susan P Buchbinder; Connie Celum; Matthew M Cousins; Deborah Donnell; Susan H Eshleman
HIV incidence determination in the United States: a multiassay approach.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacquie Astemborski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gregory D Kirk; Shruti H Mehta; Jonathan Washington; Jacquie Astemborski; Ashwin Balagopal; Noya Galai; Yvonne Higgins; David L Thomas
HIV, Age, and the Severity of Hepatitis C Virus-Related Liver Disease: A Cohort Study.
Annals of internal medicine 2013;158(9):658-66.
2013: Ludmila Prokunina-Olsson; Barbara Rehermann; Faruk Sheikh; Wei Tang; McAnthony Tarway; David L Thomas; Heiyoung Park; Ruth M Pfeiffer; Patricia Porter-Gill; Jacquie Astemborski; Herbert L Bonkovsky; Nathan Brand; Sabrina Chen; Harold Dickensheets; Raymond P Donnelly; Brian R Edlin; Dianna Hergott; Charles D Howell; Indu kohaar; Luyang Liu; Timothy R Morgan; Brian Muchmore; Adam Mumy; Thomas R O'Brien
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
Nature genetics 2013;45(2):164-71.
2013: Oliver Laeyendecker; Joseph B Margolick; Shruti Hemendra Mehta; Caroline E Mullis; Thomas C Quinn; George R Seage; Lisa P Jacobson; Gregory D Kirk; Jacob Konikoff; Jacquie Astemborski; Ron Brookmeyer; Joelle Brown; Susan P Buchbinder; Connie Celum; Matthew M Cousins; Deborah Donnell; Susan H Eshleman
HIV incidence determination in the United States: a multiassay approach.
The Journal of infectious diseases 2013;207(2):232-9.
2012: Supriya Munshaw; Jeffrey Quinn; Stuart C Ray; David L Thomas; Michael Torbenson; Jacquie Astemborski; Kasper Daniel Hansen; Hyon S Hwang; Shruti Hemendra Mehta; Ashwin Balagopal
Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.
Hepatology (Baltimore, Md.) 2012;56(2):544-54.
2012: M Bradley Drummond; Gregory D Kirk; Mariah M Marshall; John F McDyer; Shruti Hemendra Mehta; Jacquie Astemborski; Robert H Brown; Robert Wise; Christian A Merlo
Association between obstructive lung disease and markers of HIV infection in a high-risk cohort.
Thorax 2012;67(4):309-14.
2012: Shruti Hemendra Mehta; Mark S Sulkowski; Nezam H Afdhal; Jacquie Astemborski; Gregory D Kirk; David L Thomas
Stability of liver fibrosis among HCV-infected injection drug users.
Antiviral therapy 2012;17(5):813-21.
2011: Nidhi Khosla; Gregory D Kirk; Jacquie Astemborski; Hee-Soon Juon; Shruti Hemendra Mehta
Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City.
Addictive behaviors 2011;36(12):1282-7.
2011: Fuat Kurbanov; Rachel Latanich; Nabiel Mh Mikhail; Mostafa Mohamed; Mohamed Abdel-Hamid; Jacquie Astemborski; Mai El-Daly; Sherif El-Kafrawy; David L Thomas; Chloe L Thio
Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.
The Journal of infectious diseases 2011;204(9):1391-4.
2011: Nafisa-Katrin Seich Al Basatena; Chloe L Thio; Koichiro Usuku; Alison M Vine; Jacquie Astemborski; Charles R M Bangham; Mary Carrington; Sharyne M Donfield; James J Goedert; Salim I Khakoo; Gregory D Kirk; Aidan Macnamara; Mitsuhiro Osame; Becca Asquith
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection.
PLoS pathogens 2011;7(10):e1002270.
2011: Marija Zeremski; David L Thomas; Jacquie Astemborski; Rositsa Dimova; Andrew H Talal
CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.
The Journal of infectious diseases 2011;204(6):832-6.
2011: Shruti Hemendra Mehta; Jacquie Astemborski; Gregory D Kirk; Steffanie A Strathdee; Kenrad E Nelson; David Vlahov; David L Thomas
Changes in blood-borne infection risk among injection drug users.
The Journal of infectious diseases 2011;203(5):587-94.
2011: Maria Salgado; Gregory D Kirk; Andrea L Cox; Alleluiah Rutebemberwa; Yvonne Higgins; Jacquie Astemborski; David L Thomas; Chloe L Thio; Mark S Sulkowski; Joel N Blankson
Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors.
AIDS (London, England) 2011;25(3):385-7.
2011: Peter Bacchetti; Ross Boylan; Jacquie Astemborski; Hui Shen; Shruti Hemendra Mehta; David L Thomas; Norah A Terrault; Alexander Monto
Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis.
PloS one 2011;6(5):e20104.
2011: M Bradley Drummond; Gregory D Kirk; Jacquie Astemborski; Meredith CHRISTINE McCormack; Mariah M Marshall; Shruti Hemendra Mehta; Robert Wise; Christian A Merlo
Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users.
International journal of chronic obstructive pulmonary disease 2011;6():89-95.
2010: Shruti Hemendra Mehta; Gregory D Kirk; Jacquie Astemborski; Noya Galai; David Celentano
Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(12):1664-71.
2009: Gregory D Kirk; Jacquie Astemborski; Shruti Hemendra Mehta; Chuck Spoler; Cedric Fisher; Danisha Allen; Yvonne Higgins; Richard D Moore; Nezem Afdhal; Michael Torbenson; Mark S Sulkowski; David L Thomas
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(7):963-72.
2009: Ravi Kavasery; Noya Galai; Jacquie Astemborski; Gregory M Lucas; David Celentano; Gregory D Kirk; Shruti Hemendra Mehta
Nonstructured treatment interruptions among injection drug users in Baltimore, MD.
Journal of acquired immune deficiency syndromes (1999) 2009;50(4):360-6.
2008: Alleluiah Rutebemberwa; Stuart C Ray; Jacquie Astemborski; Jordana Levine; Lin Liu; Kimberly A Dowd; Shalyn Clute; Changyu Wang; Alan Korman; Alessandro Sette; John Sidney; Drew M Pardoll; Andrea L Cox
High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(12):8215-25.
2008: Jonathan E Golub; Jacquie Astemborski; Mohammed Ahmed; Wendy A Cronin; Shruti Hemendra Mehta; Gregory D Kirk; David Vlahov; Richard E Chaisson
Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2008;49(5):532-7.
2008: Chloe L Thio; Jacquie Astemborski; Rasmi Thomas; Timothy Mosbruger; Mallory D Witt; James J Goedert; Keith Hoots; Cherie Winkler; David L Thomas; Mary Carrington
Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(11):7944-7.
2008: Joel N Blankson; Donna Klinzman; Jacquie Astemborski; David L Thomas; Gregory D Kirk; Jack T Stapleton
Low frequency of GB virus C viremia in a cohort of HIV-1-infected elite suppressors.
AIDS (London, England) 2008;22(17):2398-400.
2008: Ashwin Balagopal; FRANCES PHILP; Jacquie Astemborski; Timothy M Block; Anand Mehta; Ronald Long; Gregory D Kirk; Shruti Hemendra Mehta; Andrea L Cox; David L Thomas; Stuart C Ray
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.
Gastroenterology 2008;135(1):226-33.
2008: Shruti Hemendra Mehta; Becky L Genberg; Jacquie Astemborski; Ravi Kavasery; Gregory D Kirk; David Vlahov; Steffanie A Strathdee; David L Thomas
Limited uptake of hepatitis C treatment among injection drug users.
Journal of community health 2008;33(3):126-33.
2008: Janardan P Pandey; Yuqun Luo; Robert C Elston; Yuping Wu; FRANCES PHILP; Jacquie Astemborski; David L Thomas; Dale Netski
Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2.
Human immunology 2008;69(3):158-64.
2007: Xiao-Hong Wang; Dale Netski; Jacquie Astemborski; Shruti Hemendra Mehta; Michael Torbenson; David L Thomas; Stuart C Ray
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.
Journal of virology 2007;81(12):6513-22.
2007: Shruti Hemendra Mehta; Gregory M Lucas; Jacquie Astemborski; Gregory D Kirk; David Vlahov; Noya Galai
Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users.
AIDS care 2007;19(5):637-45.
2007: Dale Netski; Timothy Mosbruger; Jacquie Astemborski; Shruti Hemendra Mehta; David L Thomas; Andrea L Cox
CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
The Journal of infectious diseases 2007;195(6):857-63.
2007: Chloe L Thio; Jacquie Astemborski; Arman Bashirova; Timothy Mosbruger; Spencer Greer; Mallory D Witt; James J Goedert; Margaret W Hilgartner; Audrey Majeske; Stephen J O'Brien; David L Thomas; Mary Carrington
Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
Journal of virology 2007;81(2):441-5.
2006: Shruti Hemendra Mehta; Noya Galai; Jacquie Astemborski; David Celentano; Steffanie A Strathdee; David Vlahov; Kenrad E Nelson
HIV incidence among injection drug users in Baltimore, Maryland (1988-2004).
Journal of acquired immune deficiency syndromes (1999) 2006;43(3):368-72.
2006: Lucy E Wilson; Michael Torbenson; Jacquie Astemborski; Hawazin Faruki; Charles Spoler; Rudra Rai; Shruti Hemendra Mehta; Gregory D Kirk; Kenrad E Nelson; Nezam H Afdhal; David L Thomas
Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2006;43(4):788-95.
2006: Shruti Hemendra Mehta; Jacquie Astemborski; Timothy R Sterling; David L Thomas; David Vlahov
Serum albumin as a prognostic indicator for HIV disease progression.
AIDS research and human retroviruses 2006;22(1):14-21.
2005: Chloe L Thio; Timothy Mosbruger; Jacquie Astemborski; Spencer Greer; Gregory D Kirk; Stephen J O'Brien; David L Thomas
Mannose binding lectin genotypes influence recovery from hepatitis B virus infection.
Journal of virology 2005;79(14):9192-6.
2005: Thomas B Kelleher; Shruti Hemendra Mehta; Ramakrishnan Bhaskar; Mark S Sulkowski; Jacquie Astemborski; David L Thomas; Richard E Moore; Nezam H Afdhal
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
Journal of hepatology 2005;43(1):78-84.
2005: Timothy R Sterling; Tracy Pisell-Noland; John L Perez; Jacquie Astemborski; Joelle R McGriff; Lisa Nutting; Donald R Hoover; David Vlahov; Robert Bollinger
Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals.
The Journal of infectious diseases 2005;191(6):881-5.
2004: Charlene S Dezzutti; Jacquie Astemborski; David L Thomas; James H Marshall; Thania Cabrera; Michael Purdy; David Vlahov; Richard S Garfein
Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2004;31(3):210-4.
2004: Chloe L Thio; Timothy Mosbruger; Richard A Kaslow; Christopher L Karp; Steffanie A Strathdee; David Vlahov; Stephen J O'Brien; Jacquie Astemborski; David L Thomas
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
Journal of virology 2004;78(20):11258-62.
2004: Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret W Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
Science (New York, N.Y.) 2004;305(5685):872-4.
2004: Chloe L Thio; James J Goedert; Timothy Mosbruger; David Vlahov; Steffanie A Strathdee; Stephen J O'Brien; Jacquie Astemborski; David L Thomas
An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection.
Genes and immunity 2004;5(4):294-300.
2004: Janardan P Pandey; Jacquie Astemborski; David L Thomas
Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus.
Journal of virology 2004;78(9):4561-5.
2004: Michael Torbenson; Rajesh Kannangai; Jacquie Astemborski; Steffanie A Strathdee; David Vlahov; David L Thomas
High prevalence of occult hepatitis B in Baltimore injection drug users.
Hepatology (Baltimore, Md.) 2004;39(1):51-7.
2003: Chloe L Thio; David L Thomas; Peter Karacki; Xiaojiang Gao; Darlene Marti; Richard A Kaslow; James J Goedert; Margaret W Hilgartner; Steffanie A Strathdee; Priya Duggal; Stephen J O'Brien; Jacquie Astemborski; Mary Carrington
Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection.
Journal of virology 2003;77(22):12083-7.
2003: Elizabeth T Golub; Jacquie Astemborski; Donald R Hoover; James C Anthony; David Vlahov; Steffanie A Strathdee
Psychological distress and progression to AIDS in a cohort of injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2003;32(4):429-34.
2002: Timothy R Sterling; Donald R Hoover; Jacquie Astemborski; David Vlahov; John G Bartlett; Jorg Schupbach
Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
The Journal of infectious diseases 2002;186(8):1181-5.
2002: Lucy E Wilson; David L Thomas; Jacquie Astemborski; Terri L Freedman; David Vlahov
Prospective study of infective endocarditis among injection drug users.
The Journal of infectious diseases 2002;185(12):1761-6.
2002: Rudra Rai; Lucy E Wilson; Jacquie Astemborski; Frank A Anania; Michael Torbenson; Charles Spoler; David Vlahov; Steffanie A Strathdee; John K Boitnott; Kenrad E Nelson; David L Thomas
Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.
Hepatology (Baltimore, Md.) 2002;35(5):1247-55.
2002: Chloe L Thio; Xiaojiang Gao; James J Goedert; David Vlahov; Kenrad E Nelson; Margaret W Hilgartner; Stephen J O'Brien; Peter Karacki; Jacquie Astemborski; Mary Carrington; David L Thomas
HLA-Cw*04 and hepatitis C virus persistence.
Journal of virology 2002;76(10):4792-7.
2001: Lucy E Wilson; T Umemura; Jacquie Astemborski; Stuart C Ray; Harvey Alter; Steffanie A Strathdee; David Vlahov; David L Thomas
Dynamics of SEN virus infection among injection drug users.
The Journal of infectious diseases 2001;184(10):1315-9.
2001: P Sadaphal; Jacquie Astemborski; Neil M H Graham; L Sheely; M Bonds; A Madison; David Vlahov; David L Thomas; Timothy R Sterling
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(10):1687-91.
2001: Linda Ahdieh; R S Klein; Robert D Burk; Susan Cu-Uvin; Paula Schuman; Ann Duerr; M Safaeian; Jacquie Astemborski; R Daniel; Keerti V Shah
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.
The Journal of infectious diseases 2001;184(6):682-90.
2001: Chloe L Thio; David L Thomas; James J Goedert; David Vlahov; Kenrad E Nelson; Margaret W Hilgartner; Stephen J O'Brien; Peter Karacki; Darlene Marti; Jacquie Astemborski; Mary Carrington
Racial differences in HLA class II associations with hepatitis C virus outcomes.
The Journal of infectious diseases 2001;184(1):16-21.
2001: David L Thomas; Josiah D Rich; Paula Schuman; Dawn Smith; Jacquie Astemborski; KR Nolt; R S Klein
Multicenter evaluation of hepatitis C RNA levels among female injection drug users.
The Journal of infectious diseases 2001;183(6):973-6.
2001: Timothy R Sterling; David Vlahov; Jacquie Astemborski; Donald R Hoover; Joseph B Margolick; Thomas C Quinn
Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
The New England journal of medicine 2001;344(10):720-5.
2000: David L Thomas; Jacquie Astemborski; RM Rai; Frank A Anania; M Schaeffer; Noya Galai; KR Nolt; Kenrad E Nelson; Steffanie A Strathdee; LISETTE JOHNSON-HILL; Oliver Laeyendecker; John K Boitnott; Lucy E Wilson; David Vlahov
The natural history of hepatitis C virus infection: host, viral, and environmental factors.
JAMA : the journal of the American Medical Association 2000;284(4):450-6.
2000: David L Thomas; Jacquie Astemborski; David Vlahov; Steffanie A Strathdee; Stuart C Ray; Kenrad E Nelson; Noya Galai; KR Nolt; Oliver Laeyendecker; J A Todd
Determinants of the quantity of hepatitis C virus RNA.
The Journal of infectious diseases 2000;181(3):844-51.
2000: Chloe L Thio; KR Nolt; Jacquie Astemborski; David Vlahov; Kenrad E Nelson; David L Thomas
Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.
Journal of clinical microbiology 2000;38(2):575-7.
1999: Timothy R Sterling; CM Lyles; David Vlahov; Jacquie Astemborski; Joseph B Margolick; Thomas C Quinn
Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters.
The Journal of infectious diseases 1999;180(3):666-72.
1999: M Kimura; Paul J Converse; Jacquie Astemborski; J S Rothel; David Vlahov; George W Comstock; Neil M H Graham; Richard E Chaisson; William R Bishai
Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.
The Journal of infectious diseases 1999;179(5):1297-300.
1999: Anne M Rompalo; Jacquie Astemborski; Ellie E Schoenbaum; Paula Schuman; C Carpenter; Scott D Holmberg; DL Warren; Homayoon Farzadegan; David Vlahov; Dawn Smith
Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(5):448-54.
1999: Chloe L Thio; Mary Carrington; Darlene Marti; Stephen J O'Brien; David Vlahov; Kenrad E Nelson; Jacquie Astemborski; David L Thomas
Class II HLA alleles and hepatitis B virus persistence in African Americans.
The Journal of infectious diseases 1999;179(4):1004-6.
1999: Patrizio Pezzotti; Noya Galai; David Vlahov; Giovanni Rezza; CM Lyles; Jacquie Astemborski
Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(3):275-82.
1999: CM Lyles; Neil M H Graham; Jacquie Astemborski; David Vlahov; Joseph B Margolick; Alfred J Saah; Homayoon Farzadegan
Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men.
European journal of epidemiology 1999;15(2):99-108.
1998: CM Lyles; David Vlahov; Homayoon Farzadegan; Jacquie Astemborski; Joseph B Margolick; B A Masters; John T Schroeder; Thomas C Quinn
Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups.
Journal of clinical microbiology 1998;36(12):3647-52.
1998: William R Bishai; Neil M H Graham; S Harrington; Diana Pope; N Hooper; Jacquie Astemborski; L Sheely; David Vlahov; Gregory E Glass; Richard E Chaisson
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy.
JAMA : the journal of the American Medical Association 1998;280(19):1679-84.
1998: Homayoon Farzadegan; Donald R Hoover; Jacquie Astemborski; CM Lyles; Joseph B Margolick; Richard B Markham; Thomas C Quinn; David Vlahov
Sex differences in HIV-1 viral load and progression to AIDS.
Lancet 1998;352(9139):1510-4.
1998: Timothy R Sterling; Richard D Moore; Neil M H Graham; Jacquie Astemborski; David Vlahov; Richard E Chaisson
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.
AIDS (London, England) 1998;12(12):1451-7.
1998: David L Thomas; David Vlahov; Harvey Alter; J C Hunt; R Marshall; Jacquie Astemborski; Kenrad E Nelson
Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.
The Journal of infectious diseases 1998;177(3):539-42.
1997: David L Thomas; Y Nakatsuji; James Shih; Harvey Alter; Kenrad E Nelson; Jacquie Astemborski; CM Lyles; David Vlahov
Persistence and clinical significance of hepatitis G virus infections in injecting drug users.
The Journal of infectious diseases 1997;176(3):586-92.
1997: CM Lyles; Joseph B Margolick; Jacquie Astemborski; Neil M H Graham; James C Anthony; Donald R Hoover; David Vlahov
The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.
AIDS (London, England) 1997;11(10):1255-62.
1997: Paul J Converse; S L Jones; Jacquie Astemborski; David Vlahov; Neil M H Graham
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection.
The Journal of infectious diseases 1997;176(1):144-50.
1996: S B Manoff; Homayoon Farzadegan; ALVARO MUNOZ; Jacquie Astemborski; David Vlahov; R T Rizzo; L Solomon; Neil M H Graham
The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users.
The Journal of infectious diseases 1996;174(2):299-308.
1996: Noya Galai; Joseph B Margolick; Jacquie Astemborski; David Vlahov
Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users.
Clinical immunology and immunopathology 1996;79(2):134-41.
1996: Neil M H Graham; Noya Galai; Kenrad E Nelson; Jacquie Astemborski; M Bonds; R T Rizzo; L Sheeley; David Vlahov
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
Archives of internal medicine 1996;156(8):889-94.
1994: Waleska Caiaffa; David Vlahov; Neil M H Graham; Jacquie Astemborski; L Solomon; Kenrad E Nelson; ALVARO MUNOZ
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users.
American journal of respiratory and critical care medicine 1994;150(6 Pt 1):1493-8.
1994: David Vlahov; Jacquie Astemborski; L Solomon; Kenrad E Nelson
Field effectiveness of needle disinfection among injecting drug users.
Journal of acquired immune deficiency syndromes 1994;7(7):760-6.
1994: David Vlahov; ALVARO MUNOZ; L Solomon; Jacquie Astemborski; A Lindsay; Jean R Anderson; Noya Galai; Kenrad E Nelson
Comparison of clinical manifestations of HIV infection between male and female injecting drug users.
AIDS (London, England) 1994;8(6):819-23.
1994: Joseph B Margolick; ALVARO MUNOZ; David Vlahov; Jacquie Astemborski; L Solomon; X Y He; Kenrad E Nelson; Alfred J Saah
Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
Archives of internal medicine 1994;154(8):869-75.
1994: Jacquie Astemborski; David Vlahov; D Warren; L Solomon; Kenrad E Nelson
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.
American journal of public health 1994;84(3):382-7.
1994: David Vlahov; Jacquie Astemborski; L Solomon; Noya Galai; L Basarab; Kenrad E Nelson
Interest in HIV vaccines among injection drug users in Baltimore, Maryland.
AIDS research and human retroviruses 1994;10 Suppl 2():S265-8.
1994: Kenrad E Nelson; David Vlahov; Noya Galai; Jacquie Astemborski; L Solomon
Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
AIDS research and human retroviruses 1994;10 Suppl 2():S201-5.
1993: Homayoon Farzadegan; David Vlahov; L Solomon; ALVARO MUNOZ; Jacquie Astemborski; E Taylor; A Burnley; Kenrad E Nelson
Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users.
The Journal of infectious diseases 1993;168(2):327-31.
1993: L Solomon; Jacquie Astemborski; D Warren; ALVARO MUNOZ; Sylvia Cohn; David Vlahov; Kenrad E Nelson
Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users.
American journal of epidemiology 1993;137(8):892-8.
1992: David Vlahov; M Sullivan; Jacquie Astemborski; Kenrad E Nelson
Bacterial infections and skin cleaning prior to injection among intravenous drug users.
Public health reports (Washington, D.C. : 1974) 1992;107(5):595-8.
1992: Joseph B Margolick; ALVARO MUNOZ; David Vlahov; L Solomon; Jacquie Astemborski; Sylvia Cohn; Kenrad E Nelson
Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
JAMA : the journal of the American Medical Association 1992;267(12):1631-6.
1992: Neil M H Graham; Kenrad E Nelson; L Solomon; M Bonds; R T Rizzo; J Scavotto; Jacquie Astemborski; David Vlahov
Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
JAMA : the journal of the American Medical Association 1992;267(3):369-73.
1992: ALVARO MUNOZ; David Vlahov; L Solomon; Joseph B Margolick; J C Bareta; Sylvia Cohn; Jacquie Astemborski; Kenrad E Nelson
Prognostic indicators for development of AIDS among intravenous drug users.
Journal of acquired immune deficiency syndromes 1992;5(7):694-700.
1991: James C Anthony; David Vlahov; Kenrad E Nelson; Sylvia Cohn; Jacquie Astemborski; L Solomon
New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
American journal of epidemiology 1991;134(10):1175-89.
1991: L Solomon; R Frank; David Vlahov; Jacquie Astemborski
Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus.
American journal of public health 1991;81(10):1285-90.